Search

Author/Creator Geynisman, Daniel M.

1. Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma. (18th December 2015)

Authors:
Geynisman, Daniel M.; Handorf, Elizabeth; Wong, Yu‐Ning; Doyle, Jamie; Plimack, Elizabeth R.; Horwitz, Eric M.; Canter, Daniel J.; Uzzo, Robert G.; Kutikov, Alexander; Smaldone, Marc C.
Journal:
Cancer medicine
Issue:
Volume 5:Number 2(2016:Feb.)
Page Start:
192
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Comparative cost‐effectiveness of neoadjuvant chemotherapy regimens for muscle‐invasive bladder cancer: Results according to VESPER data. Issue 24 (17th October 2022)

Authors:
Joyce, Daniel D.; Wymer, Kevin M.; Sharma, Vidit; Moriarty, James P.; Borah, Bijan J.; Geynisman, Daniel M.; Plimack, Elizabeth R.; Costello, Brian A.; Pagliaro, Lance C.; Boorjian, Stephen A.
Journal:
Cancer
Issue:
Volume 128:Issue 24(2022)
Page Start:
4194
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder‐preservation therapy for muscle‐invasive bladder cancer. Issue 22 (25th July 2017)

Authors:
Cahn, David B.; Handorf, Elizabeth A.; Ghiraldi, Eric M.; Ristau, Benjamin T.; Geynisman, Daniel M.; Churilla, Thomas M.; Horwitz, Eric M.; Sobczak, Mark L.; Chen, David Y. T.; Viterbo, Rosalia; Greenberg, Richard E.; Kutikov, Alexander; Uzzo, Robert G.; Smaldone, Marc C.
Journal:
Cancer
Issue:
Volume 123:Issue 22(2017)
Page Start:
4337
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Cost-effectiveness of pembrolizumab with axitinib as first-line treatment for advanced renal cell carcinoma. (1st September 2020)

Authors:
Bensimon, Arielle G.; Zhong, Yichen; Swami, Umang; Briggs, Allison; Young, Joshua; Feng, Yuan; Song, Yan; Signorovitch, James; Adejoro, Oluwakayode; Chakravarty, Abhiroop; Chen, Mei; Perini, Rodolfo F.; Geynisman, Daniel M.
Journal:
Current medical research and opinion
Issue:
Volume 36:Number 9(2020)
Page Start:
1507
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin‐Based Chemotherapy for Muscle‐Invasive Bladder Cancer. (6th February 2019)

Authors:
Osterman, Chelsea K.; Babu, Dilip S.; Geynisman, Daniel M.; Lewis, Bianca; Somer, Robert A.; Balar, Arjun V.; Zibelman, Matthew R.; Guancial, Elizabeth A.; Antinori, Gianna; Yu, Shun; Narayan, Vivek; Guzzo, Thomas J.; Plimack, Elizabeth R.; Vaughn, David J.; Fung, Chunkit; Mamtani, Ronac
Journal:
Oncologist
Issue:
Volume 24:Number 5(2019)
Page Start:
688
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Immune‐Related Adverse Events as a Biomarker in Non‐Melanoma Patients Treated with Programmed Cell Death 1 Inhibitors. (26th June 2017)

Authors:
Judd, Julia; Zibelman, Matthew; Handorf, Elizabeth; O'Neill, John; Ramamurthy, Chethan; Bentota, Sasini; Doyle, Jamie; Uzzo, Robert G.; Bauman, Jessica; Borghaei, Hossein; Plimack, Elizabeth R.; Mehra, Ranee; Geynisman, Daniel M.
Journal:
Oncologist
Issue:
Volume 22:Number 10(2017)
Page Start:
1232
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗